Evaluation on blood biomarkers related with outcomes in patients with stable anigina pectoris undergoing percutaneous coronary intervention

Evaluation on blood biomarkers related with outcomes in patients with stable anigina pectoris undergoing percutaneous coronary intervention - Evaluation on blood biomarkers related with outcomes in patients with stable anigina pectoris undergoing percutaneous coronary intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029283

Enrollment

144

Registered

2017-09-25

Start date

2008-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with stable angina undergoing percutaneous coronary intervention

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: stable angina pectoris undergoing their first percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: 1.New York Heart Association functional classification of >III 2.malignant disease with an expected prognosis of <1 year 3.chronic inflammatory disease 4.chronic renal failure (serum creatinine concentration of >2.0mg/dl) 5. Patinets who did not provide written informed consent

Design outcomes

Primary

Measure	Time frame
cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, revascularization, and hospitalization for heart failure.	—

Countries

Japan

Contacts

Public ContactToru Miyoshi

Okayama University Hospital Cardiovascular Medicine

miyoshit@cc.okayama-u.ac.jp086-235-7351

Outcome results